Dr. Philipp Hahn
Phillip Hahn joined the Berlin Institute of Health as Head of Strategic Affairs end of 2016. Previously, he has been responsible for the research field health in the head office of the Helmholtz-Association of German Research Centers, by far Germanys largest research organization, for the past seven years. Phillip Hahn obtained a PhD from the TU Braunschweig and the Helmholtz-Centre for Infection Research and has worked as executive officer to the CEO at the Helmholtz-Centre for Infection Research for several years.
The Berlin Institute of Health (BIH) has a social mission: to foster medical innovation and therefore improve patients’ health and quality of life.
BIH aims to provide research solutions enabling the transformation of medical care into a value-based model for the 21st century. To achieve this, we have to address different areas in the translational research space and clinical practice: We need a new generation of translationally trained researchers with an integrative, translational and entrepreneurial approach as well as an effective digitization and (inter)national interoperability of relevant processes in the clinics and research departments, to allow translational and personalized medicine approaches to draw on digital clinical information systems, and validated health records and samples.
The BIH is committed to improving our understanding on how bodily systems interact to enable personalized predictions for treatments, prevention and well-being in the future. In addition, we aim to complement these approaches by advancing technologies such as gene, cell and nanoscale therapies to tackle unmet needs in individuals. To bring these precision medicine approaches into practice, it will not only need further advancements in science but also a cultural and behavioral shift among clinicians, researchers and patients as they will become engaged partners for each individuals health.